TY - JOUR
T1 - Treatment strategy after noncurative endoscopic resection for early gastric cancers in patients aged ≥ 85 years
T2 - a multicenter retrospective study in a highly aged area of Japan
AU - for Tohoku GI Endoscopy Group
AU - Hatta, Waku
AU - Toya, Yosuke
AU - Shimada, Tomohiro
AU - Hamada, Koichi
AU - Watanabe, Ko
AU - Nakamura, Jun
AU - Fukushi, Daisuke
AU - Koike, Tomoyuki
AU - Shinkai, Hirohiko
AU - Ito, Hirotaka
AU - Matsuhashi, Tamotsu
AU - Fujimori, Shusei
AU - Iwai, Wataru
AU - Hanabata, Norihiro
AU - Shiroki, Takeharu
AU - Sasaki, Yu
AU - Fujishima, Yuukou
AU - Tsuji, Tsuyotoshi
AU - Yorozu, Haruka
AU - Yoshimura, Tetsuro
AU - Horikawa, Yohei
AU - Takahashi, Yasushi
AU - Takahashi, Hiroshi
AU - Kondo, Yutaka
AU - Fujiwara, Takao
AU - Mizugai, Hisata
AU - Gonai, Takahiro
AU - Tatsuta, Tetsuya
AU - Onochi, Kengo
AU - Kudara, Norihiko
AU - Abe, Keinosuke
AU - Ogata, Yohei
AU - Ohira, Tetsuya
AU - Horikawa, Yoshinori
AU - Ishihata, Ryoichi
AU - Hikichi, Takuto
AU - Satoh, Kennichi
AU - Iijima, Katsunori
AU - Fukuda, Shinsaku
AU - Matsumoto, Takayuki
AU - Masamune, Atsushi
N1 - Publisher Copyright:
© 2023, Japanese Society of Gastroenterology.
PY - 2023/4
Y1 - 2023/4
N2 - Background: The guidelines recommend additional gastrectomy after noncurative endoscopic resection for early gastric cancers (EGCs). However, no additional treatment might be acceptable in some patients aged ≥ 85 years. We aimed to identify this patient group using the data in a highly aged area. Methods: We enrolled patients aged ≥ 85 years after noncurative endoscopic resection for EGCs at 30 institutions of the Tohoku district in Japan between 2002 and 2017. Treatment selection and prognosis after noncurative endoscopic resection were investigated. Fourteen candidates were evaluated using the Cox model to identify risk factors for poor overall survival (OS) in patients with no additional treatment. Results: Of 1065 patients aged ≥ 85 years, 143 underwent noncurative endoscopic resection. Despite the guidelines’ recommendation, 88.8% of them underwent no additional treatment. The 5-year OS rates in those with additional gastrectomy and those with no additional treatment were 63.1 and 65.2%, respectively. Multivariate analysis showed independent risk factors for poor OS in patients with no additional treatment were the high-risk category in the eCura system (hazard ratio [HR], 2.91), Charlson comorbidity index (CCI) ≥ 3 (HR, 2.78), and male (HR, 2.04). In patients with no additional treatment, nongastric cancer-specific survival was low (69.0% in 5 years), whereas disease-specific survival rates were very high in the low- and intermediate-risk categories of the eCura system (100.0 and 97.1%, respectively, in 5 years). Conclusions: No additional treatment may be acceptable in the low- and intermediate-risk categories of the eCura system in patients aged ≥ 85 years with noncurative endoscopic resection for EGCs.
AB - Background: The guidelines recommend additional gastrectomy after noncurative endoscopic resection for early gastric cancers (EGCs). However, no additional treatment might be acceptable in some patients aged ≥ 85 years. We aimed to identify this patient group using the data in a highly aged area. Methods: We enrolled patients aged ≥ 85 years after noncurative endoscopic resection for EGCs at 30 institutions of the Tohoku district in Japan between 2002 and 2017. Treatment selection and prognosis after noncurative endoscopic resection were investigated. Fourteen candidates were evaluated using the Cox model to identify risk factors for poor overall survival (OS) in patients with no additional treatment. Results: Of 1065 patients aged ≥ 85 years, 143 underwent noncurative endoscopic resection. Despite the guidelines’ recommendation, 88.8% of them underwent no additional treatment. The 5-year OS rates in those with additional gastrectomy and those with no additional treatment were 63.1 and 65.2%, respectively. Multivariate analysis showed independent risk factors for poor OS in patients with no additional treatment were the high-risk category in the eCura system (hazard ratio [HR], 2.91), Charlson comorbidity index (CCI) ≥ 3 (HR, 2.78), and male (HR, 2.04). In patients with no additional treatment, nongastric cancer-specific survival was low (69.0% in 5 years), whereas disease-specific survival rates were very high in the low- and intermediate-risk categories of the eCura system (100.0 and 97.1%, respectively, in 5 years). Conclusions: No additional treatment may be acceptable in the low- and intermediate-risk categories of the eCura system in patients aged ≥ 85 years with noncurative endoscopic resection for EGCs.
KW - Early gastric cancers
KW - Noncurative endoscopic resection
KW - Patients aged ≥ 85 years
KW - eCura system
UR - http://www.scopus.com/inward/record.url?scp=85146258251&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85146258251&partnerID=8YFLogxK
U2 - 10.1007/s00535-022-01948-7
DO - 10.1007/s00535-022-01948-7
M3 - Article
C2 - 36633664
AN - SCOPUS:85146258251
SN - 0944-1174
VL - 58
SP - 346
EP - 357
JO - Journal of Gastroenterology
JF - Journal of Gastroenterology
IS - 4
ER -